Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer.

Clin Cancer Res · 2025 · PMC11739782 · PMID 39513959

Europe PMC DOI

hedged sentence

0.0270

closest p · 0.5× alpha

0.0270

boldest claim

The sentences

borderline significantP = 0.027actually significant

BAY 1895344 treatment resulted in some growth inhibition and borderline significant prolonged time to tumor doubling (EFS-2: 7 days control vs. 18 days BAY 1895344; P = 0.027).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.